{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:33:25Z","timestamp":1786995205095,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.oooo.2016.09.225","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T15:35:51Z","timestamp":1476632151000},"page":"220-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Histochemical observation of bony reversal lines in bisphosphonate-related osteonecrosis of the jaw"],"prefix":"10.1016","volume":"123","author":[{"given":"Soung Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Young","family":"Eo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Keun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2016.09.225_bib1","first-page":"78","article-title":"Differences among bisfosfonates\u2014specificity of risedronate (Actonel)","volume":"55","author":"Giljevic","year":"2008","journal-title":"Reumatizam"},{"key":"10.1016\/j.oooo.2016.09.225_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1196\/annals.1365.036","article-title":"Bisphosphonates","volume":"1092","author":"Lambrinoudaki","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.oooo.2016.09.225_bib3","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","article-title":"The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs","volume":"103","author":"Kavanagh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.oooo.2016.09.225_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/187152012799014959","article-title":"The chemistry of bisphosphonates: from antiscaling agents to clinical therapeutics","volume":"12","author":"Widler","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.oooo.2016.09.225_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1470-2045(13)70539-4","article-title":"Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial","volume":"15","author":"Barrett-Lee","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.oooo.2016.09.225_bib6","first-page":"47","article-title":"Treatment of osteoporosis with diphosphonates","volume":"2","author":"Saville","year":"1972","journal-title":"Semin Drug Treat"},{"key":"10.1016\/j.oooo.2016.09.225_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0960-7404(96)80014-4","article-title":"Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model","volume":"5","author":"Tamura","year":"1996","journal-title":"Surg Oncol"},{"key":"10.1016\/j.oooo.2016.09.225_bib8","first-page":"235","article-title":"Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment","volume":"42","author":"Smith","year":"1973","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.oooo.2016.09.225_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(73)93215-7","article-title":"Diphosphonates and vitamin-D metabolism in Paget's disease","volume":"2","author":"Bonjour","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.oooo.2016.09.225_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1359\/JBMR.041113","article-title":"Gorham-Stout disease\u2014stabilization during bisphosphonate treatment","volume":"20","author":"Hammer","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.oooo.2016.09.225_bib11","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.joms.2015.06.154","article-title":"Fatal progression of Gorham disease: a case report and review of the literature","volume":"73","author":"Kim","year":"2015","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.09.225_bib12","first-page":"643","article-title":"A\u00a0new bisphosphonate treatment option for giant cell tumors","volume":"8","author":"Fujimoto","year":"2001","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oooo.2016.09.225_bib13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1302\/0301-620X.91B8.21518","article-title":"The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years","volume":"91","author":"Agarwala","year":"2009","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.oooo.2016.09.225_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.09.225_bib15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2016.09.225_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bjps.2006.06.016","article-title":"Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate","volume":"61","author":"Lobato","year":"2008","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.oooo.2016.09.225_bib17","first-page":"417","article-title":"A\u00a0review of bisphosphonate-associated osteonecrosis of the jaws and its management","volume":"73","author":"Lam","year":"2007","journal-title":"J\u00a0Can Dent Assoc"},{"key":"10.1016\/j.oooo.2016.09.225_bib18","first-page":"96","article-title":"Bisphosphonate-related osteonecrosis of the jaws","volume":"29","author":"Ruggiero","year":"2008","journal-title":"Compend Contin Educ Dent"},{"key":"10.1016\/j.oooo.2016.09.225_bib19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","article-title":"Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome","volume":"18","author":"Yarom","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.oooo.2016.09.225_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oooo.2016.09.225_bib21","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4158\/EP.14.9.1150","article-title":"Bisphosphonate-associated osteomyelitis of the jaw: guidelines for practicing clinicians","volume":"14","author":"Wimalawansa","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.oooo.2016.09.225_bib22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.oooo.2016.09.225_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management","volume":"102","author":"Ruggiero","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2016.09.225_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tripleo.2006.12.004","article-title":"Bisphosphonates and osteonecrosis of the jaws: science and rationale","volume":"104","author":"Gutta","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2016.09.225_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ncponc1000","article-title":"Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle","volume":"4","author":"Bertoldo","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.oooo.2016.09.225_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","article-title":"Giant osteoclast formation and long-term oral bisphosphonate therapy","volume":"360","author":"Weinstein","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2016.09.225_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteopetrosis","volume":"349","author":"Whyte","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2016.09.225_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.pcan.4500607","article-title":"The potential role of bisphosphonates in prostate cancer","volume":"5","author":"Oades","year":"2002","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.oooo.2016.09.225_bib29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1359\/jbmr.2002.17.6.998","article-title":"Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice","volume":"17","author":"Deckers","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.oooo.2016.09.225_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jcms.2005.07.007","article-title":"Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?","volume":"33","author":"Lenz","year":"2005","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2016.09.225_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14712\/fb2007053040143","article-title":"Risedronate has no adverse effects on mouse haematopoiesis","volume":"53","author":"Sefc","year":"2007","journal-title":"Folia Biol (Praha)"},{"key":"10.1016\/j.oooo.2016.09.225_bib32","first-page":"73","article-title":"Androgens, cardiovascular disease and osteoporosis","volume":"28","author":"Isidori","year":"2005","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.oooo.2016.09.225_bib33","first-page":"181","article-title":"Recurrent Osteomyelitis caused by bisphosphonate intake showed abnormal osteophytes lack of Harversian system","volume":"33","author":"Park","year":"2009","journal-title":"Kor J Oral Maxillofac Pathol"},{"key":"10.1016\/j.oooo.2016.09.225_bib34","first-page":"183","article-title":"Ultrastructural changes of bone in bisphosphonate-related osteonecrosis of jaws","volume":"37","author":"Lee","year":"2013","journal-title":"Kor J Oral Maxillofac Pathol"},{"key":"10.1016\/j.oooo.2016.09.225_bib35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S8756-3282(01)00429-X","article-title":"Bisphosphonate acts on osteoclasts independent of ruffled borders in osteosclerotic (oc\/oc) mice","volume":"28","author":"Ito","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.oooo.2016.09.225_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00223-012-9570-0","article-title":"Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits","volume":"90","author":"Turek","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.oooo.2016.09.225_bib37","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jbmr.66","article-title":"Near-infrared fluorescent probe traces bisphosphonate delivery and retention in\u00a0vivo","volume":"25","author":"Kozloff","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.oooo.2016.09.225_bib38","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.oooo.2016.09.225_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00198-013-2514-3","article-title":"Molecular alterations of bone quality in sequesters of bisphosphonates-related osteonecrosis of the jaws","volume":"25","author":"Olejnik","year":"2014","journal-title":"Osteoporos Int"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440316306125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440316306125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:33:56Z","timestamp":1749638036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440316306125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2212440316306125"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2016.09.225","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histochemical observation of bony reversal lines in bisphosphonate-related osteonecrosis of the jaw","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2016.09.225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}